(Q42758783)

6 November 2017

Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents (English)

1 reference

6 November 2017

1 reference

A Holstein

1

1 reference

6 November 2017

A Plaschke

2

1 reference

6 November 2017

M Ptak

3

1 reference

6 November 2017

E-H Egberts

4

1 reference

6 November 2017

J El-Din

5

1 reference

6 November 2017

J Brockmöller

6

1 reference

6 November 2017

J Kirchheiner

7

1 reference

6 November 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

British Journal of Clinical Pharmacology

6 November 2017

1 reference

6 November 2017

60

1 reference

6 November 2017

1

1 reference

6 November 2017

103-106

1 reference

Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use

6 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884896

Risk of Hypoglycaemia with Oral Antidiabetic Agents in Patients with Type 2 Diabetes

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884896

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884896

Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteers

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884896

Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884896

Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884896

Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884896

Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884896

Pharmacogenetics of tolbutamide metabolism in humans

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15963101

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

CYP2C9*3 allelic variant and bleeding complications

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15963101

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2005.02379.X

1 reference

6 November 2017

1 reference

6 November 2017

PubMed publication ID

15963101

1 reference